What is the ACIP recommendation for RSV vaccination of older adults?

ACIP routinely recommends a single dose of any of the three licensed RSV vaccines for all adults age 75 years and older. ACIP also recommends a single dose of any RSV vaccine for adults age 50 through 74 years who are increased risk for serious RSV infection due to specific high-risk conditions, frailty, or high-risk living arrangements (e.g., residents of long-term care facilities). Refer to the question and answer about high-risk conditions for which CDC recommends vaccination among adults age 50 through 74 years for the detailed list.

In April 2025, ACIP voted to lower the age for initiating vaccination of high-risk adults from age 60 years to age 50 years. The recommendation was accepted and made official in the summer of 2025. The indications for those age 50 through 59 years are the same as those published for people age 60 through 74 years. See the detailed MMWR publication of the ACIP recommendation for older adults, including those at high risk beginning at age 60 years here: www.cdc.gov/acip-recs/hcp/vaccine-specific/rsv.html.